Recent Progress on Therapeutic Vaccines for Breast Cancer.
Ontology highlight
ABSTRACT: Breast cancer remains the most frequently diagnosed malignancy worldwide. Advanced breast cancer is still an incurable disease mainly because of its heterogeneity and limited immunogenicity. The great success of cancer immunotherapy is paving the way for a new era in cancer treatment, and therapeutic cancer vaccination is an area of interest. Vaccine targets include tumor-associated antigens and tumor-specific antigens. Immune responses differ in different vaccine delivery platforms. Next-generation sequencing technologies and computational analysis have recently made personalized vaccination possible. However, only a few cases benefiting from neoantigen-based treatment have been reported in breast cancer, and more attention has been given to overexpressed antigen-based treatment, especial
SUBMITTER: Zhang L
PROVIDER: S-EPMC9207208 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA